Cardioplegia solution administration kit
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
09-11-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Haemonetics Australia Pty Ltd
Class:
Class IIa
Manufactured by:
Haemonetics Corporation 125 Summer Street, Boston, Massachusetts, 02110 United States Of America
Therapeutic area:
16163 - Cardioplegia solution administration kit
Therapeutic indications:
Removal of inadvertent particulate debris, microbiological contaminants and their associated endotoxins from cardioplegia solution being injected into the heart.
Authorization status:
A
Authorization date:
2014-04-17
